hip osteoarthritis
Conditions
Interventions
From date of approval march 2016 to 31 march 2018. All patients were performed total hip arthroplasty. A : 50 patients used acetaminophen intravenous All patients were randomly selected. Acetamino
Sponsors
Hyogo colleage of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: The patient who received the primary total hip arthroplasty which was not included in exclusion criteria.
Exclusion criteria
Exclusion criteria: Patients have a liver function disorder, a renal function disorder. In disease severity of the liver function, we exclude the cases more than grade 2 or class B from the object of this study with "pharmaceutical products side effect serious degree classification" "Child-Pugh classification". In disease severity of the renal function, we excluded the case of Ccr<59. Cases with a history of the past of hypersensitivity. The cases that has difficulty in mutual understanding in self.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pre-operative assessment Numerical Rating Scale (NRS) value. Post-operative assessment NRS (0 hour, 6 hours, 12 hours, 18 hours, 24 hours, 36 hours, 48 hours) | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient Controlled Analgesia used amount Opioid consumption volume of 24 hours Postoperative liver function evaluation during 2weeks | — |
Countries
Japan
Contacts
Public ContactMaiko Koike
Hyogo college of medicine Department of Orthropaedic Surgery
Outcome results
None listed